I principali analisti di Wall Street hanno emesso valutazioni di acquisto per il titolo Moderna ma solo a brevissimo termine. Sell. #block-survival { display: none; } @media only screen and (min-width: 75rem) { .multiple-lines-intraday-chart .content-3-up__item.content-3-up__item { flex-basis: 31%; }} Type a symbol or company name. Jefferies Financial Group’s price objective points to a potential upside of 5.42% from the stock’s previous close. Type a symbol or company name. The Moderna Analyst: Oppenheimer analyst Hartaj Singh maintained an Outperform rating and $108 price target. A number of other research firms have also weighed in on MRNA. The average price target for Moderna stock calculated from the table below is $192.67. And so with MRNA crossing above that average target price of $89.58/share, investors in MRNA have been given a good signal to spend fresh time assessing the company and deciding for themselves: is $89.58 just one stop on the way to an even higher target, or has the valuation gotten stretched to the point where it is time to think about taking some chips off the table? Argus increased their target price on Moderna from $88.00 to $200.00 and gave the company a “buy” rating in a report on Tuesday, December 1st. Finally, Jefferies Financial Group reiterated a buy rating and set a $90.00 price objective on shares of Moderna in a research note on Wednesday, August 12th. Moderna (NASDAQ:MRNA) had its price target reduced by Morgan Stanley from $215.00 to $201.00 in a report released on Thursday, Benzinga reports. Is Moderna Stock a good buy in 2021, according to Wall Street analysts? What price target have analysts set for MRNA? Number of Analysts Highest Target Price Lowest Target Price Average Target Price Current Price Upside Potential; 15: $166: $60: $112.87: $146.81-23.12%: MRNA Broker Recommendations Summary. © 2021, Nasdaq, Inc. All Rights Reserved. /*-->*/. When the symbol you want to add appears, add it to Watchlist by selecting it and pressing Enter/Return. Today’s Change. What is MRNA's forecast return on equity (ROE) for 2021-2024? Today ||| 52-Week Range. The Top 25 Cryptocurrencies to Know in 2021: BTC, ETH, XRP, XLM and More, Christie's $69M NFT Sale 'Like Nothing I Have Ever Seen,' Says Art Auction Specialist, U.S. 0 analysts 0%. Moderna Inc (MRNA) Price Targets From Analysts. Moderna had its target price raised by Piper Sandler to $134 from $100. In recent trading, shares of Moderna Inc (Symbol: MRNA) have crossed above the average analyst 12-month target price of $89.58, changing hands for $97.95/share. But the whole reason to look at the average MRNA price target in the first place is to tap into a "wisdom of crowds" effort, putting together the contributions of all the individual minds who contributed to the ultimate number, as opposed to what just one particular expert believes. Moderna Inc. got a new Wall Street-high price target from Goldman Sachs as its shares traded at a record after the biotech company revealed positive early … Moderna closed at $129.75 on Wednesday, that is a 32.66% than the forecasted price. Morgan Stanley have made an estimate for Moderna … Here Are 2 Things Investors Should Know, Lit Markets Provide Price Improvement Too, Why AMC Entertainment Stock Gained 13% Today, 2 Top Stocks Investors Should Buy Right Now, data provided by Zacks Investment Research via Quandl.com, Get the latest Zacks research report on MRNA — FREE, Top 25 Broker Analyst Picks of the S&P 500, Analyst target price data provided by Zacks Investment Research via Quandl.com, Get the latest Zacks research report on MRNA - FREE, Do Not Sell My Personal Information (CA Residents Only). Outsmart the market with Smart Portfolio analytical tools powered by TipRanks. 18 Wall Street analysts have issued ratings and price targets for Moderna in the last 12 months. BMO Capital Markets boosted their target price on Moderna from $94.00 to $112.00 and gave the company an outperform rating in a research note on Monday, July 27th. Buy. BNK Invest caters to investing firms and individual investors internationally. Price *Price Target Lowest: 35.00 Median: 106.11 Highest: 215.00 *The average price target includes all analyst analysis, not just the most recent analysis presented in the chart. Target Price: 155,38 $ Media del giudizio di 13 analisti Target Price Moderna Inc Tra i 13 analisti che hanno dato i consensi, questo è il range di Target Price assegnato a Moderna Inc Moderna Inc quote is equal to 129.870 USD at 2021-03-11. MRNA has been the subject of several other research reports. This article used data provided by Zacks Investment Research via Quandl.com. Should I buy or sell MRNA stock? The new note on the price target was released on July 20, 2020, representing the official price target for Moderna Inc. stock. Jefferies rated Moderna as ‘Buy’ with a target price of $90. Copy and paste multiple symbols separated by spaces. AFTER HOURS 7:59 PM EST 03/05/21. What is MRNA's earnings growth forecast for 2021-2023? What is MRNA's forecast return on assets (ROA) for 2021-2024? The brokerage currently has an “equal weight” rating on the stock. There are 12 different analyst targets contributing to that average for Moderna Inc, but the average is just that — a mathematical average. WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security. Based on our forecasts, a long-term increase is expected, the "MRNA" stock price prognosis for 2026-03-06 is 306.264 USD. What is MRNA's Earnings Per Share (EPS) forecast for 2021-2023? With a 5-year investment, the revenue is expected to be around +135.82%. The Top 25 Broker Analyst Picks of the S&P 500 ». ET by Tomi Kilgore Walgreens to receive 1 mln COVID-19 vaccine doses from J&J, Moderna … $132.13 -0.06 -0.05%. The company presently has an average rating of Buy and an average target price of $112.16. Morgan Stanley currently has an equal weight rating on the stock. 1 analysts 6.25%. Analysis on target price and performance of stocks is usually carefully studied by market experts, and the current Wall Street consensus on MRNA stock is a recommendation set at 2.50. When a stock reaches the target an analyst has set, the analyst logically has two ways to react: downgrade on valuation, or, re-adjust their target price to a higher level. Hold. [CDATA[/* >